Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00669526 · ClinicalTrials.gov registry record · Phase 2

Clinical and Cost Effectiveness of Brief Cognitive-Behavioral Therapy (CBT) for Pediatric Internalizing Disorders

A Phase 2 study, sponsored by Robert Wood Johnson Foundation.

Completed
Registry status
Phase 2
Development phase
60
Enrollment target

NCT00669526 is a Phase 2 study that has completed, run by Robert Wood Johnson Foundation. The registered enrollment target is 60 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00669526, a Phase 2 study, has completed, sponsored by Robert Wood Johnson Foundation.

COMPLETED
Registry status
Phase 2
Development phase
60 participants
Enrollment target

Study Summary

This project assesses the clinical and cost effectiveness of brief cognitive-behavioral therapy (CBT) for depressed (ages 11-17) and anxious (ages 8-17) youths seen for services in pediatric primary care. This study is designed to compare the impact of brief CBT delivered on-site in pediatric primary care to referral to specialty mental health care (SMHC), as well as obtain an estimate of the total costs of the CBT protocols for depression and anxiety and the cost-effectiveness of the protocols compared to referral to and utilization of SMHC services.

Interventions

  • BEHAVIORAL BCBT
  • BEHAVIORAL SMHC referral

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2004-10
Est. Completion 2007-04
Phase Phase 2

Sponsor

Robert Wood Johnson Foundation

14 total trials

What the Registry Record Tells You About NCT00669526

The ClinicalTrials.gov registry entry for NCT00669526 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Robert Wood Johnson Foundation, which has 14 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which BCBT is the first listed.

NCT00669526 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00669526 about?

NCT00669526 is a clinical study titled "Clinical and Cost Effectiveness of Brief Cognitive-Behavioral Therapy (CBT) for Pediatric Internalizing Disorders". This project assesses the clinical and cost effectiveness of brief cognitive-behavioral therapy (CBT) for depressed (ages 11-17) and anxious (ages 8-17) youths seen for services in pediatric primary care. This study is designed to compare the impact of brief CBT delivered on-site in pediatric primar...

What is the current status of trial NCT00669526?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 60 participants. The study started on 2004-10. Estimated completion is 2007-04.

What interventions are being tested in trial NCT00669526?

The interventions under investigation include: BCBT (BEHAVIORAL), SMHC referral (BEHAVIORAL).

Who is sponsoring clinical trial NCT00669526?

This trial is sponsored by Robert Wood Johnson Foundation, which has 14 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.